NCT05237947 2026-03-19
PRISMA
National Cancer Institute (NCI)
Phase 4 Active not recruiting
Clinical Trials
6 trialsActive not recruiting × Interventional × Human Papillomavirus Recombinant Vaccine nonavalent × Clear all
NCT03036930 2026-03-11
Preventive Human Papillomavirus (HPV) Vaccine Trial in Kidney Transplant Recipients
National Cancer Institute (NCI)
Phase 2 Active not recruiting
NCT04206813 2026-01-27
An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimen
Boston Medical Center
Phase 4 Active not recruiting
NCT03023631 2025-11-18
Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
M.D. Anderson Cancer Center
Phase 4 Active not recruiting
NCT03180034 2025-09-04
ESCUDDO
National Cancer Institute (NCI)
Phase 4 Active not recruiting
NCT04270773 2024-07-10
9-VPH-MVIH
University Hospital Virgen de las Nieves
Phase 4 Active not recruiting